The DOI matches its Crossref record; 254 of the 254 references it cites were found in a registry or an index.
GPCR drug discovery: integrating solution NMR data with crystal and cryo-EM structures
Open accessAbstract
The 826 G protein-coupled receptors (GPCRs) in the human proteome regulate key physiological processes and thus have long been attractive drug targets. With the crystal structures of more than 50 different human GPCRs determined over the past decade, an initial platform for structure-based rational design has been established for drugs that target GPCRs, which is currently being augmented with cryo-electron microscopy (cryo-EM) structures of higher-order GPCR complexes. Nuclear magnetic resonance (NMR) spectroscopy in solution is one of the key approaches for expanding this platform with dynamic features, which can be accessed at physiological temperature and with minimal modification of the wild-type GPCR covalent structures. Here, we review strategies for the use of advanced biochemistry and NMR techniques with GPCRs, survey projects in which crystal or cryo-EM structures have been complemented with NMR investigations and discuss the impact of this integrative approach on GPCR biology and drug discovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Relaxation Effects in Nuclear Magnetic Resonance Absorption
Bloembergen, N., Purcell, E. M., & Pound, R. V. (1948) · Physical Review · doi:10.1103/physrev.73.679 · Cited by 6,528
Crystal Structure of Rhodopsin: A G Protein-Coupled Receptor
Palczewski, K., Kumasaka, T., Hori, T., Behnke, C. A., Motoshima, H., Fox, B. A., Trong, I. L., Teller, D. C., Okada, T., Stenkamp, R. E., et al. (2000) · Science · doi:10.1126/science.289.5480.739 · Cited by 5,637
High-Resolution Crystal Structure of an Engineered Human β 2 -Adrenergic G Protein–Coupled Receptor
Cherezov, V., Rosenbaum, D. M., Hanson, M. A., Rasmussen, S. G. F., Thian, F. S., Kobilka, T. S., Choi, H.-J., Kuhn, P., Weis, W. I., Kobilka, B. K., et al. (2007) · Science · doi:10.1126/science.1150577 · Cited by 3,264
Crystal structure of the β2 adrenergic receptor–Gs protein complex
Rasmussen, S. G. F., DeVree, B. T., Zou, Y., Kruse, A. C., Chung, K. Y., Kobilka, T. S., Thian, F. S., Chae, P. S., Pardon, E., Calinski, D., et al. (2011) · Nature · doi:10.1038/nature10361 · Cited by 3,009
Ballesteros, J. A., & Weinstein, H. (1995) · Methods in Neurosciences · doi:10.1016/s1043-9471(05)80049-7 · Cited by 2,999
Trends in GPCR drug discovery: new agents, targets and indications
Hauser, A. S., Attwood, M. M., Rask-Andersen, M., Schiöth, H. B., & Gloriam, D. E. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.178 · Cited by 2,627
The structure and function of G-protein-coupled receptors
Rosenbaum, D. M., Rasmussen, S. G. F., & Kobilka, B. K. (2009) · Nature · doi:10.1038/nature08144 · Cited by 2,534
Pervushin, K., Riek, R., Wider, G., & Wüthrich, K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12366 · Cited by 2,445
Self-citationA comprehensive map of molecular drug targets
Santos, R., Ursu, O., Gaulton, A., Bento, A. P., Donadi, R. S., Bologa, C. G., Karlsson, A., Al-Lazikani, B., Hersey, A., Oprea, T. I., et al. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.230 · Cited by 2,427
Intrinsically disordered proteins in cellular signalling and regulation
Wright, P. E., & Dyson, H. J. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3920 · Cited by 2,401
Discovering High-Affinity Ligands for Proteins: SAR by NMR
Shuker, S. B., Hajduk, P. J., Meadows, R. P., & Fesik, S. W. (1996) · Science · doi:10.1126/science.274.5292.1531 · Cited by 2,041
The 2.6 Angstrom Crystal Structure of a Human A 2A Adenosine Receptor Bound to an Antagonist
Jaakola, V.-P., Griffith, M. T., Hanson, M. A., Cherezov, V., Chien, E. Y. T., Lane, J. R., IJzerman, A. P., & Stevens, R. C. (2008) · Science · doi:10.1126/science.1164772 · Cited by 1,781
Structure of a nanobody-stabilized active state of the β2 adrenoceptor
Rasmussen, S. G. F., Choi, H.-J., Fung, J. J., Pardon, E., Casarosa, P., Chae, P. S., DeVree, B. T., Rosenbaum, D. M., Thian, F. S., Kobilka, T. S., et al. (2011) · Nature · doi:10.1038/nature09648 · Cited by 1,680
Crystal structure of the µ-opioid receptor bound to a morphinan antagonist
Manglik, A., Kruse, A. C., Kobilka, T. S., Thian, F. S., Mathiesen, J. M., Sunahara, R. K., Pardo, L., Weis, W. I., Kobilka, B. K., & Granier, S. (2012) · Nature · doi:10.1038/nature10954 · Cited by 1,356
GPCR Engineering Yields High-Resolution Structural Insights into β 2 -Adrenergic Receptor Function
Rosenbaum, D. M., Cherezov, V., Hanson, M. A., Rasmussen, S. G. F., Thian, F. S., Kobilka, T. S., Choi, H.-J., Yao, X.-J., Weis, W. I., Stevens, R. C., et al. (2007) · Science · doi:10.1126/science.1150609 · Cited by 1,336
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
Urban, J. D., Clarke, W. P., von Zastrow, M., Nichols, D. E., Kobilka, B., Weinstein, H., Javitch, J. A., Roth, B. L., Christopoulos, A., Sexton, P. M., et al. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.104463 · Cited by 1,116
Directed Self-Assembly of Monodisperse Phospholipid Bilayer Nanodiscs with Controlled Size
Denisov, I. G., Grinkova, Y. V., Lazarides, A. A., & Sligar, S. G. (2004) · Journal of the American Chemical Society · doi:10.1021/ja0393574 · Cited by 1,064
A decade of fragment-based drug design: strategic advances and lessons learned
Hajduk, P. J., & Greer, J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2220 · Cited by 1,064
Recognition Dynamics Up to Microseconds Revealed from an RDC-Derived Ubiquitin Ensemble in Solution
Lange, O. F., Lakomek, N.-A., Farès, C., Schröder, G. F., Walter, K. F. A., Becker, S., Meiler, J., Grubmüller, H., Griesinger, C., & de Groot, B. L. (2008) · Science · doi:10.1126/science.1157092 · Cited by 1,044
Twenty years on: the impact of fragments on drug discovery
Erlanson, D. A., Fesik, S. W., Hubbard, R. E., Jahnke, W., & Jhoti, H. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.109 · Cited by 1,000
Structure and dynamics of GPCR signaling complexes
Hilger, D., Masureel, M., & Kobilka, B. K. (2018) · Nature Structural & Molecular Biology · doi:10.1038/s41594-017-0011-7 · Cited by 969
PERVUSHIN, K., RIEK, R., WIDER, G., & WÜTHRICH, K. (2021) · NMR with Biological Macromolecules in Solution · doi:10.1142/9789811235795_0006 · Cited by 951
Self-citationStructural Basis for Allosteric Regulation of GPCRs by Sodium Ions
Liu, W., Chun, E., Thompson, A. A., Chubukov, P., Xu, F., Katritch, V., Han, G. W., Roth, C. B., Heitman, L. H., IJzerman, A. P., et al. (2012) · Science · doi:10.1126/science.1219218 · Cited by 945
Structure-based discovery of opioid analgesics with reduced side effects
Manglik, A., Lin, H., Aryal, D. K., McCorvy, J. D., Dengler, D., Corder, G., Levit, A., Kling, R. C., Bernat, V., Hübner, H., et al. (2016) · Nature · doi:10.1038/nature19112 · Cited by 944
Hanson, M. A., Cherezov, V., Griffith, M. T., Roth, C. B., Jaakola, V.-P., Chien, E. Y. T., Velasquez, J., Kuhn, P., & Stevens, R. C. (2008) · Structure · doi:10.1016/j.str.2008.05.001 · Cited by 933
Crystal structure of the ligand-free G-protein-coupled receptor opsin
Park, J. H., Scheerer, P., Hofmann, K. P., Choe, H.-W., & Ernst, O. P. (2008) · Nature · doi:10.1038/nature07063 · Cited by 903
Structural insights into µ-opioid receptor activation
Huang, W., Manglik, A., Venkatakrishnan, A. J., Laeremans, T., Feinberg, E. N., Sanborn, A. L., Kato, H. E., Livingston, K. E., Thorsen, T. S., Kling, R. C., et al. (2015) · Nature · doi:10.1038/nature14886 · Cited by 885
Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation
Lebon, G., Warne, T., Edwards, P. C., Bennett, K., Langmead, C. J., Leslie, A. G. W., & Tate, C. G. (2011) · Nature · doi:10.1038/nature10136 · Cited by 873
Trends in the exploitation of novel drug targets
Rask-Andersen, M., Almén, M. S., & Schiöth, H. B. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3478 · Cited by 853
GPCR Dynamics: Structures in Motion
Latorraca, N. R., Venkatakrishnan, A. J., & Dror, R. O. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00177 · Cited by 835
Structure of an Agonist-Bound Human A 2A Adenosine Receptor
Xu, F., Wu, H., Katritch, V., Han, G. W., Jacobson, K. A., Gao, Z.-G., Cherezov, V., & Stevens, R. C. (2011) · Science · doi:10.1126/science.1202793 · Cited by 813
Structure and dynamics of the M3 muscarinic acetylcholine receptor
Kruse, A. C., Hu, J., Pan, A. C., Arlow, D. H., Rosenbaum, D. M., Rosemond, E., Green, H. F., Liu, T., Chae, P. S., Dror, R. O., et al. (2012) · Nature · doi:10.1038/nature10867 · Cited by 811
Structure of the human histamine H1 receptor complex with doxepin
Shimamura, T., Shiroishi, M., Weyand, S., Tsujimoto, H., Winter, G., Katritch, V., Abagyan, R., Cherezov, V., Liu, W., Han, G. W., et al. (2011) · Nature · doi:10.1038/nature10236 · Cited by 804
The Dynamic Process of β2-Adrenergic Receptor Activation
Nygaard, R., Zou, Y., Dror, R. O., Mildorf, T. J., Arlow, D. H., Manglik, A., Pan, A. C., Liu, C. W., Fung, J. J., Bokoch, M. P., et al. (2013) · Cell · doi:10.1016/j.cell.2013.01.008 · Cited by 796
Self-Assembly of Discoidal Phospholipid Bilayer Nanoparticles with Membrane Scaffold Proteins
Bayburt, T. H., Grinkova, Y. V., & Sligar, S. G. (2002) · Nano Letters · doi:10.1021/nl025623k · Cited by 784
Clore, G. M., & Iwahara, J. (2009) · Chemical Reviews · doi:10.1021/cr900033p · Cited by 782
Biased signalling: from simple switches to allosteric microprocessors
Smith, J. S., Lefkowitz, R. J., & Rajagopal, S. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.229 · Cited by 738
Biased Signaling Pathways in β 2 -Adrenergic Receptor Characterized by 19 F-NMR
Liu, J. J., Horst, R., Katritch, V., Stevens, R. C., & Wüthrich, K. (2012) · Science · doi:10.1126/science.1215802 · Cited by 697
Self-citationStructural Insights into the Dynamic Process of β2-Adrenergic Receptor Signaling
Manglik, A., Kim, T. H., Masureel, M., Altenbach, C., Yang, Z., Hilger, D., Lerch, M. T., Kobilka, T. S., Thian, F. S., Hubbell, W. L., et al. (2015) · Cell · doi:10.1016/j.cell.2015.04.043 · Cited by 665
Structural Features for Functional Selectivity at Serotonin Receptors
Wacker, D., Wang, C., Katritch, V., Han, G. W., Huang, X.-P., Vardy, E., McCorvy, J. D., Jiang, Y., Chu, M., Siu, F. Y., et al. (2013) · Science · doi:10.1126/science.1232808 · Cited by 664
Structure of the µ-opioid receptor–Gi protein complex
Koehl, A., Hu, H., Maeda, S., Zhang, Y., Qu, Q., Paggi, J. M., Latorraca, N. R., Hilger, D., Dawson, R., Matile, H., et al. (2018) · Nature · doi:10.1038/s41586-018-0219-7 · Cited by 658
Tugarinov, V., Hwang, P. M., Ollerenshaw, J. E., & Kay, L. E. (2003) · Journal of the American Chemical Society · doi:10.1021/ja030153x · Cited by 649
DeWire, S. M., Yamashita, D. S., Rominger, D. H., Liu, G., Cowan, C. L., Graczyk, T. M., Chen, X.-T., Pitis, P. M., Gotchev, D., Yuan, C., et al. (2013) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.201616 · Cited by 647
The structural basis for agonist and partial agonist action on a β1-adrenergic receptor
Warne, T., Moukhametzianov, R., Baker, J. G., Nehmé, R., Edwards, P. C., Leslie, A. G. W., Schertler, G. F. X., & Tate, C. G. (2011) · Nature · doi:10.1038/nature09746 · Cited by 618
Pharmacogenomics of GPCR Drug Targets
Hauser, A. S., Chavali, S., Masuho, I., Jahn, L. J., Martemyanov, K. A., Gloriam, D. E., & Babu, M. M. (2018) · Cell · doi:10.1016/j.cell.2017.11.033 · Cited by 616
A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling
Wisler, J. W., DeWire, S. M., Whalen, E. J., Violin, J. D., Drake, M. T., Ahn, S., Shenoy, S. K., & Lefkowitz, R. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707936104 · Cited by 597
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: g protein-coupled receptors
Alexander, S. P., Christopoulos, A., Davenport, A. P., Kelly, E., Marrion, N. V., Peters, J. A., Faccenda, E., Harding, S. D., Pawson, A. J., Sharman, J. L., et al. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13878 · Cited by 588
G-Protein-coupled receptor oligomerization and its potential for drug discovery
George, S. R., O'Dowd, B. F., & Lee, S. P. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd913 · Cited by 588
Molecular Mechanism of β-Arrestin-Biased Agonism at Seven-Transmembrane Receptors
Reiter, E., Ahn, S., Shukla, A. K., & Lefkowitz, R. J. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105800 · Cited by 583
Cryo-EM structure of the activated GLP-1 receptor in complex with a G protein
Zhang, Y., Sun, B., Feng, D., Hu, H., Chu, M., Qu, Q., Tarrasch, J. T., Li, S., Sun Kobilka, T., Kobilka, B. K., et al. (2017) · Nature · doi:10.1038/nature22394 · Cited by 576
Bias factor and therapeutic window correlate to predict safer opioid analgesics
Schmid, C. L., Kennedy, N. M., Ross, N. C., Lovell, K. M., Yue, Z., Morgenweck, J., Cameron, M. D., Bannister, T. D., & Bohn, L. M. (2017) · Cell · doi:10.1016/j.cell.2017.10.035 · Cited by 567
How Ligands Illuminate GPCR Molecular Pharmacology
Wacker, D., Stevens, R. C., & Roth, B. L. (2017) · Cell · doi:10.1016/j.cell.2017.07.009 · Cited by 560
The Role of Science in Addressing the Opioid Crisis
Volkow, N. D., & Collins, F. S. (2017) · New England Journal of Medicine · doi:10.1056/nejmsr1706626 · Cited by 555
Structure of the Adenosine A2A Receptor in Complex with ZM241385 and the Xanthines XAC and Caffeine
Doré, A. S., Robertson, N., Errey, J. C., Ng, I., Hollenstein, K., Tehan, B., Hurrell, E., Bennett, K., Congreve, M., Magnani, F., et al. (2011) · Structure · doi:10.1016/j.str.2011.06.014 · Cited by 553
GPCRdb in 2018: adding GPCR structure models and ligands
Pándy-Szekeres, G., Munk, C., Tsonkov, T. M., Mordalski, S., Harpsøe, K., Hauser, A. S., Bojarski, A. J., & Gloriam, D. E. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1109 · Cited by 553
Structure of the agonist-bound neurotensin receptor
White, J. F., Noinaj, N., Shibata, Y., Love, J., Kloss, B., Xu, F., Gvozdenovic-Jeremic, J., Shah, P., Shiloach, J., Tate, C. G., et al. (2012) · Nature · doi:10.1038/nature11558 · Cited by 509
Functional Selectivity and Biased Receptor Signaling
Kenakin, T. (2011) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.173948 · Cited by 505
Molecular control of δ-opioid receptor signalling
Fenalti, G., Giguere, P. M., Katritch, V., Huang, X.-P., Thompson, A. A., Cherezov, V., Roth, B. L., & Stevens, R. C. (2014) · Nature · doi:10.1038/nature12944 · Cited by 497
Nanodiscs in Membrane Biochemistry and Biophysics
Denisov, I. G., & Sligar, S. G. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00690 · Cited by 493
Adrenaline-activated structure of β2-adrenoceptor stabilized by an engineered nanobody
Ring, A. M., Manglik, A., Kruse, A. C., Enos, M. D., Weis, W. I., Garcia, K. C., & Kobilka, B. K. (2013) · Nature · doi:10.1038/nature12572 · Cited by 491
Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic
Thompson, A. A., Liu, W., Chun, E., Katritch, V., Wu, H., Vardy, E., Huang, X.-P., Trapella, C., Guerrini, R., Calo, G., et al. (2012) · Nature · doi:10.1038/nature11085 · Cited by 477
Ligand-specific regulation of the extracellular surface of a G-protein-coupled receptor
Bokoch, M. P., Zou, Y., Rasmussen, S. G. F., Liu, C. W., Nygaard, R., Rosenbaum, D. M., Fung, J. J., Choi, H.-J., Thian, F. S., Kobilka, T. S., et al. (2010) · Nature · doi:10.1038/nature08650 · Cited by 470
Phase-plate cryo-EM structure of a class B GPCR–G-protein complex
Liang, Y.-L., Khoshouei, M., Radjainia, M., Zhang, Y., Glukhova, A., Tarrasch, J., Thal, D. M., Furness, S. G. B., Christopoulos, G., Coudrat, T., et al. (2017) · Nature · doi:10.1038/nature22327 · Cited by 462
Cryo-EM in drug discovery: achievements, limitations and prospects
Renaud, J.-P., Chari, A., Ciferri, C., Liu, W.-T., Rémigy, H.-W., Stark, H., & Wiesmann, C. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.77 · Cited by 461
Bhabha, G., Lee, J., Ekiert, D. C., Gam, J., Wilson, I. A., Dyson, H. J., Benkovic, S. J., & Wright, P. E. (2011) · Science · doi:10.1126/science.1198542 · Cited by 460
Structure of the adenosine A2A receptor bound to an engineered G protein
Carpenter, B., Nehmé, R., Warne, T., Leslie, A. G. W., & Tate, C. G. (2016) · Nature · doi:10.1038/nature18966 · Cited by 435
β2 Adrenergic Receptor Activation
Shi, L., Liapakis, G., Xu, R., Guarnieri, F., Ballesteros, J. A., & Javitch, J. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206801200 · Cited by 422
Pellecchia, M., Sem, D. S., & Wüthrich, K. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd748 · Cited by 420
Self-citationMOLECULAR MECHANISM OF 7TM RECEPTOR ACTIVATION—A GLOBAL TOGGLE SWITCH MODEL
Schwartz, T. W., Frimurer, T. M., Holst, B., Rosenkilde, M. M., & Elling, C. E. (2006) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141218 · Cited by 408
Adenosine A2A receptors and basal ganglia physiology
Schiffmann, S. N., Fisone, G., Moresco, R., Cunha, R. A., & Ferré, S. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.05.001 · Cited by 397
Co-inhibition of CD73 and A2AR Adenosine Signaling Improves Anti-tumor Immune Responses
Young, A., Ngiow, S. F., Barkauskas, D. S., Sult, E., Hay, C., Blake, S. J., Huang, Q., Liu, J., Takeda, K., Teng, M. W. L., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.06.025 · Cited by 388
Protein NMR Using Paramagnetic Ions
Otting, G. (2010) · Annual Review of Biophysics · doi:10.1146/annurev.biophys.093008.131321 · Cited by 387
Gether, U. (1997) · The EMBO Journal · doi:10.1093/emboj/16.22.6737 · Cited by 386
Biophysics in drug discovery: impact, challenges and opportunities
Renaud, J.-P., Chung, C.-W., Danielson, U. H., Egner, U., Hennig, M., Hubbard, R. E., & Nar, H. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.123 · Cited by 382
A clinical review of GLP-1 receptor agonists: efficacy and safety in diabetes and beyond
Prasad-Reddy, L., & Isaacs, D. (2015) · Drugs in Context · doi:10.7573/dic.212283 · Cited by 365
Two disparate ligand-binding sites in the human P2Y1 receptor
Zhang, D., Gao, Z.-G., Zhang, K., Kiselev, E., Crane, S., Wang, J., Paoletta, S., Yi, C., Ma, L., Zhang, W., et al. (2015) · Nature · doi:10.1038/nature14287 · Cited by 365
Biased ligands at G-protein-coupled receptors: promise and progress
Violin, J. D., Crombie, A. L., Soergel, D. G., & Lark, M. W. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.04.007 · Cited by 363
Coupling ligand structure to specific conformational switches in the β2-adrenoceptor
Yao, X., Parnot, C., Deupi, X., Ratnala, V. R. P., Swaminath, G., Farrens, D., & Kobilka, B. (2006) · Nature Chemical Biology · doi:10.1038/nchembio801 · Cited by 353
Activation of the A2A adenosine G-protein-coupled receptor by conformational selection
Ye, L., Van Eps, N., Zimmer, M., Ernst, O. P., & Scott Prosser, R. (2016) · Nature · doi:10.1038/nature17668 · Cited by 348
Single-molecule analysis of ligand efficacy in β2AR–G-protein activation
Gregorio, G. G., Masureel, M., Hilger, D., Terry, D. S., Juette, M., Zhao, H., Zhou, Z., Perez-Aguilar, J. M., Hauge, M., Mathiasen, S., et al. (2017) · Nature · doi:10.1038/nature22354 · Cited by 345
Bajaj, V. S., Mak-Jurkauskas, M. L., Belenky, M., Herzfeld, J., & Griffin, R. G. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900908106 · Cited by 337
Allosteric Modulation as a Unifying Mechanism for Receptor Function and Regulation
Changeux, J.-P., & Christopoulos, A. (2016) · Cell · doi:10.1016/j.cell.2016.08.015 · Cited by 336
Staus, D. P., Strachan, R. T., Manglik, A., Pani, B., Kahsai, A. W., Kim, T. H., Wingler, L. M., Ahn, S., Chatterjee, A., Masoudi, A., et al. (2016) · Nature · doi:10.1038/nature18636 · Cited by 330
Observing biological dynamics at atomic resolution using NMR
Mittermaier, A. K., & Kay, L. E. (2009) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2009.07.004 · Cited by 323
Structure of the adenosine-bound human adenosine A1 receptor–Gi complex
Draper-Joyce, C. J., Khoshouei, M., Thal, D. M., Liang, Y.-L., Nguyen, A. T. N., Furness, S. G. B., Venugopal, H., Baltos, J.-A., Plitzko, J. M., Danev, R., et al. (2018) · Nature · doi:10.1038/s41586-018-0236-6 · Cited by 317
Ghanouni, P., Steenhuis, J. J., Farrens, D. L., & Kobilka, B. K. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101126198 · Cited by 311
Allosteric regulation of G protein–coupled receptor activity by phospholipids
Dawaliby, R., Trubbia, C., Delporte, C., Masureel, M., Van Antwerpen, P., Kobilka, B. K., & Govaerts, C. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.1960 · Cited by 304
G-protein-coupled receptor inactivation by an allosteric inverse-agonist antibody
Hino, T., Arakawa, T., Iwanari, H., Yurugi-Kobayashi, T., Ikeda-Suno, C., Nakada-Nakura, Y., Kusano-Arai, O., Weyand, S., Shimamura, T., Nomura, N., et al. (2012) · Nature · doi:10.1038/nature10750 · Cited by 296
A saposin-lipoprotein nanoparticle system for membrane proteins
Frauenfeld, J., Löving, R., Armache, J.-P., Sonnen, A. F.-P., Guettou, F., Moberg, P., Zhu, L., Jegerschöld, C., Flayhan, A., Briggs, J. A. G., et al. (2016) · Nature Methods · doi:10.1038/nmeth.3801 · Cited by 293
Biased agonism: An emerging paradigm in GPCR drug discovery
Rankovic, Z., Brust, T. F., & Bohn, L. M. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.12.024 · Cited by 282
Self-assembly of size-controlled liposomes on DNA nanotemplates
Yang, Y., Wang, J., Shigematsu, H., Xu, W., Shih, W. M., Rothman, J. E., & Lin, C. (2016) · Nature Chemistry · doi:10.1038/nchem.2472 · Cited by 271
Iwahara, J., Tang, C., & Marius Clore, G. (2007) · Journal of Magnetic Resonance · doi:10.1016/j.jmr.2006.10.003 · Cited by 266
Tracking G-protein-coupled receptor activation using genetically encoded infrared probes
Ye, S., Zaitseva, E., Caltabiano, G., Schertler, G. F. X., Sakmar, T. P., Deupi, X., & Vogel, R. (2010) · Nature · doi:10.1038/nature08948 · Cited by 263
Covalently circularized nanodiscs for studying membrane proteins and viral entry
Nasr, M. L., Baptista, D., Strauss, M., Sun, Z.-Y. J., Grigoriu, S., Huser, S., Plückthun, A., Hagn, F., Walz, T., Hogle, J. M., et al. (2017) · Nature Methods · doi:10.1038/nmeth.4079 · Cited by 262
Restructuring G-Protein- Coupled Receptor Activation
Audet, M., & Bouvier, M. (2012) · Cell · doi:10.1016/j.cell.2012.09.003 · Cited by 262
Soergel, D. G., Subach, R. A., Burnham, N., Lark, M. W., James, I. E., Sadler, B. M., Skobieranda, F., Violin, J. D., & Webster, L. R. (2014) · Pain · doi:10.1016/j.pain.2014.06.011 · Cited by 262
Cryo-EM structure of human rhodopsin bound to an inhibitory G protein
Kang, Y., Kuybeda, O., de Waal, P. W., Mukherjee, S., Van Eps, N., Dutka, P., Zhou, X. E., Bartesaghi, A., Erramilli, S., Morizumi, T., et al. (2018) · Nature · doi:10.1038/s41586-018-0215-y · Cited by 261
Conn, P. J., Lindsley, C. W., Meiler, J., & Niswender, C. M. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4308 · Cited by 260
Propagation of conformational changes during μ-opioid receptor activation
Sounier, R., Mas, C., Steyaert, J., Laeremans, T., Manglik, A., Huang, W., Kobilka, B. K., Déméné, H., & Granier, S. (2015) · Nature · doi:10.1038/nature14680 · Cited by 255
β-Arrestin-biased Agonism at the β2-Adrenergic Receptor
Drake, M. T., Violin, J. D., Whalen, E. J., Wisler, J. W., Shenoy, S. K., & Lefkowitz, R. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708118200 · Cited by 254
Non-Analgesic Effects of Opioids: Opioid-induced Respiratory Depression
Boom, M., Niesters, M., Sarton, E., Aarts, L., W. Smith, T., & Dahan, A. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212803582469 · Cited by 252
Multiple ligand-specific conformations of the β2-adrenergic receptor
Kahsai, A. W., Xiao, K., Rajagopal, S., Ahn, S., Shukla, A. K., Sun, J., Oas, T. G., & Lefkowitz, R. J. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.634 · Cited by 250
The effect of ligand efficacy on the formation and stability of a GPCR-G protein complex
Yao, X. J., Vélez Ruiz, G., Whorton, M. R., Rasmussen, S. G. F., DeVree, B. T., Deupi, X., Sunahara, R. K., & Kobilka, B. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811437106 · Cited by 246
Antimetastatic Effects of Blocking PD-1 and the Adenosine A2A Receptor
Mittal, D., Young, A., Stannard, K., Yong, M., Teng, M. W. L., Allard, B., Stagg, J., & Smyth, M. J. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0957 · Cited by 245
Nanobody stabilization of G protein-coupled receptor conformational states
Steyaert, J., & Kobilka, B. K. (2011) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2011.06.011 · Cited by 234
A2aR antagonists: Next generation checkpoint blockade for cancer immunotherapy
Leone, R. D., Lo, Y.-C., & Powell, J. D. (2015) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2015.03.008 · Cited by 225
Opioid dependence treatment: options in pharmacotherapy
Stotts, A. L., Dodrill, C. L., & Kosten, T. R. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903037168 · Cited by 222
Mak-Jurkauskas, M. L., Bajaj, V. S., Hornstein, M. K., Belenky, M., Griffin, R. G., & Herzfeld, J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706156105 · Cited by 221
Warne, T., Edwards, P. C., Leslie, A. G. W., & Tate, C. G. (2012) · Structure · doi:10.1016/j.str.2012.03.014 · Cited by 220
Cryo-EM structure of the serotonin 5-HT1B receptor coupled to heterotrimeric Go
García-Nafría, J., Nehmé, R., Edwards, P. C., & Tate, C. G. (2018) · Nature · doi:10.1038/s41586-018-0241-9 · Cited by 217
Identification of Protein Surfaces by NMR Measurements with a Paramagnetic Gd(III) Chelate
Pintacuda, G., & Otting, G. (2002) · Journal of the American Chemical Society · doi:10.1021/ja016985h · Cited by 216
Extra-helical binding site of a glucagon receptor antagonist
Jazayeri, A., Doré, A. S., Lamb, D., Krishnamurthy, H., Southall, S. M., Baig, A. H., Bortolato, A., Koglin, M., Robertson, N. J., Errey, J. C., et al. (2016) · Nature · doi:10.1038/nature17414 · Cited by 216
Antiparallel EmrE exports drugs by exchanging between asymmetric structures
Morrison, E. A., DeKoster, G. T., Dutta, S., Vafabakhsh, R., Clarkson, M. W., Bahl, A., Kern, D., Ha, T., & Henzler-Wildman, K. A. (2012) · Nature · doi:10.1038/nature10703 · Cited by 215
Functional reconstitution of β 2 -adrenergic receptors utilizing self-assembling Nanodisc technology
Leitz, A. J., Bayburt, T. H., Barnakov, A. N., Springer, B. A., & Sligar, S. G. (2006) · BioTechniques · doi:10.2144/000112169 · Cited by 212
Allosteric Coupling of Drug Binding and Intracellular Signaling in the A2A Adenosine Receptor
Eddy, M. T., Lee, M.-Y., Gao, Z.-G., White, K. L., Didenko, T., Horst, R., Audet, M., Stanczak, P., McClary, K. M., Han, G. W., et al. (2018) · Cell · doi:10.1016/j.cell.2017.12.004 · Cited by 212
Self-citationEgloff, P., Hillenbrand, M., Klenk, C., Batyuk, A., Heine, P., Balada, S., Schlinkmann, K. M., Scott, D. J., Schütz, M., & Plückthun, A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1317903111 · Cited by 211
Structure of the full-length glucagon class B G-protein-coupled receptor
Zhang, H., Qiao, A., Yang, D., Yang, L., Dai, A., de Graaf, C., Reedtz-Runge, S., Dharmarajan, V., Zhang, H., Han, G. W., et al. (2017) · Nature · doi:10.1038/nature22363 · Cited by 211
Chen, X.-T., Pitis, P., Liu, G., Yuan, C., Gotchev, D., Cowan, C. L., Rominger, D. H., Koblish, M., DeWire, S. M., Crombie, A. L., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4010829 · Cited by 208
Methodological advances: the unsung heroes of the GPCR structural revolution
Ghosh, E., Kumari, P., Jaiman, D., & Shukla, A. K. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3933 · Cited by 201
Opportunities for therapeutic antibodies directed at G-protein-coupled receptors
Hutchings, C. J., Koglin, M., Olson, W. C., & Marshall, F. H. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.91 · Cited by 198
Unifying Family A GPCR Theories of Activation
Tehan, B. G., Bortolato, A., Blaney, F. E., Weir, M. P., & Mason, J. S. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.02.004 · Cited by 196
Rahmeh, R., Damian, M., Cottet, M., Orcel, H., Mendre, C., Durroux, T., Sharma, K. S., Durand, G., Pucci, B., Trinquet, E., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201093109 · Cited by 196
Kofuku, Y., Ueda, T., Okude, J., Shiraishi, Y., Kondo, K., Maeda, M., Tsujishita, H., & Shimada, I. (2012) · Nature Communications · doi:10.1038/ncomms2046 · Cited by 195
Self-citationStructural Basis for G Protein-Coupled Receptor Activation
Manglik, A., & Kruse, A. C. (2017) · Biochemistry · doi:10.1021/acs.biochem.7b00747 · Cited by 194
The energy landscape of adenylate kinase during catalysis
Kerns, S. J., Agafonov, R. V., Cho, Y.-J., Pontiggia, F., Otten, R., Pachov, D. V., Kutter, S., Phung, L. A., Murphy, P. N., Thai, V., et al. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2941 · Cited by 189
Bayburt, T. H., Vishnivetskiy, S. A., McLean, M. A., Morizumi, T., Huang, C.-C., Tesmer, J. J. G., Ernst, O. P., Sligar, S. G., & Gurevich, V. V. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.151043 · Cited by 184
50 years of allosteric interactions: the twists and turns of the models
Changeux, J.-P. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3695 · Cited by 179
Backbone NMR reveals allosteric signal transduction networks in the β1-adrenergic receptor
Isogai, S., Deupi, X., Opitz, C., Heydenreich, F. M., Tsai, C.-J., Brueckner, F., Schertler, G. F. X., Veprintsev, D. B., & Grzesiek, S. (2016) · Nature · doi:10.1038/nature16577 · Cited by 177
The Role of Ligands on the Equilibria Between Functional States of a G Protein-Coupled Receptor
Kim, T. H., Chung, K. Y., Manglik, A., Hansen, A. L., Dror, R. O., Mildorf, T. J., Shaw, D. E., Kobilka, B. K., & Prosser, R. S. (2013) · Journal of the American Chemical Society · doi:10.1021/ja404305k · Cited by 176
El Moustaine, D., Granier, S., Doumazane, E., Scholler, P., Rahmeh, R., Bron, P., Mouillac, B., Banères, J.-L., Rondard, P., & Pin, J.-P. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205838109 · Cited by 173
Mu Opioid Receptor-Gi Protein Complex: 6dde
Koehl, A., Hu, H., Maeda, S., Manglik, A., Zhang, Y., Kobilka, B. K., Skiniotis, G., & Weis, W. I. (2018) · Worldwide Protein Data Bank · doi:10.2210/pdb6dde/pdb · Cited by 172
Activation mechanism of endothelin ETB receptor by endothelin-1
Shihoya, W., Nishizawa, T., Okuta, A., Tani, K., Dohmae, N., Fujiyoshi, Y., Nureki, O., & Doi, T. (2016) · Nature · doi:10.1038/nature19319 · Cited by 169
Ye, L., Neale, C., Sljoka, A., Lyda, B. R., Pichugin, D., Tsuchimura, N., Larda, S. T., Pomès, R., García, A. E., Ernst, O. P., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03314-9 · Cited by 167
A kinetic view of GPCR allostery and biased agonism
Lane, J. R., May, L. T., Parton, R. G., Sexton, P. M., & Christopoulos, A. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2431 · Cited by 166
Conformation of a peptide ligand bound to its G-protein coupled receptor.
Inooka, H., Ohtaki, T., Kitahara, O., Ikegami, T., Endo, S., Kitada, C., Ogi, K., Onda, H., Fujino, M., & Shirakawa, M. (2001) · Nature Structural Biology · doi:10.1038/84159 · Cited by 164
Structural basis of ligand binding modes at the neuropeptide Y Y1 receptor
Yang, Z., Han, S., Keller, M., Kaiser, A., Bender, B. J., Bosse, M., Burkert, K., Kögler, L. M., Wifling, D., Bernhardt, G., et al. (2018) · Nature · doi:10.1038/s41586-018-0046-x · Cited by 163
Sensitivity-Enhanced NMR Reveals Alterations in Protein Structure by Cellular Milieus
Frederick, K. K., Michaelis, V. K., Corzilius, B., Ong, T., Jacavone, A. C., Griffin, R. G., & Lindquist, S. L. (2015) · Cell · doi:10.1016/j.cell.2015.09.024 · Cited by 160
Kofuku, Y., Ueda, T., Okude, J., Shiraishi, Y., Kondo, K., Mizumura, T., Suzuki, S., & Shimada, I. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201406603 · Cited by 160
Self-citationKofuku, Y., Yoshiura, C., Ueda, T., Terasawa, H., Hirai, T., Tominaga, S., Hirose, M., Maeda, Y., Takahashi, H. K., Terashima, Y., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.024851 · Cited by 157
Self-citationHatfield, S. M., & Sitkovsky, M. V. (2016) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2016.06.009 · Cited by 155
Nanodiscs as a New Tool to Examine Lipid–Protein Interactions
Schuler, M. A., Denisov, I. G., & Sligar, S. G. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-275-9_18 · Cited by 153
Dahan, A., Sarton, E. Y., Teppema, L. J., Olievier, C. N., Nieuwenhuijs, D. J. F., Matthes, H. W. D., & Kieffer, B. L. (2001) · Anesthesiology · doi:10.1097/00000542-200105000-00021 · Cited by 153
Adenosine A2A receptors in ventral striatum, hypothalamus and nociceptive circuitry
Ferré, S., Diamond, I., Goldberg, S. R., Yao, L., Hourani, S. M. O., Huang, Z., Urade, Y., & Kitchen, I. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.04.002 · Cited by 150
The Dynamic Process of b 2 -Adrenergic Receptor Activation
Nygaard, R., Zou, Y., Dror, R. O., Mildorf, T. J., Arlow, D. H., Manglik, A., Pan, A. C., Liu, C. W., Bokoch, M. P., Thian, F. S., et al. (2013) · Cited by 146
West, G. M., Chien, E. Y. T., Katritch, V., Gatchalian, J., Chalmers, M. J., Stevens, R. C., & Griffin, P. R. (2011) · Structure · doi:10.1016/j.str.2011.08.001 · Cited by 143
Structure and Dynamics of Membrane Proteins from Solid-State NMR
Mandala, V. S., Williams, J. K., & Hong, M. (2018) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-070816-033712 · Cited by 142
Expanding the Paradigm: Intrinsically Disordered Proteins and Allosteric Regulation
Berlow, R. B., Dyson, H. J., & Wright, P. E. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.04.003 · Cited by 142
N-Terminal T4 Lysozyme Fusion Facilitates Crystallization of a G Protein Coupled Receptor
Zou, Y., Weis, W. I., & Kobilka, B. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046039 · Cited by 139
Okude, J., Ueda, T., Kofuku, Y., Sato, M., Nobuyama, N., Kondo, K., Shiraishi, Y., Mizumura, T., Onishi, K., Natsume, M., et al. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201508794 · Cited by 137
Self-citationFirst Clinical Experience With TRV130: Pharmacokinetics and Pharmacodynamics in Healthy Volunteers
Soergel, D. G., Subach, R. A., Sadler, B., Connell, J., Marion, A. S., Cowan, C. L., Violin, J. D., & Lark, M. W. (2013) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.207 · Cited by 134
Extending the Structural View of Class B GPCRs
de Graaf, C., Song, G., Cao, C., Zhao, Q., Wang, M.-W., Wu, B., & Stevens, R. C. (2017) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2017.10.003 · Cited by 133
Spontaneous Lipid Nanodisc Fomation by Amphiphilic Polymethacrylate Copolymers
Yasuhara, K., Arakida, J., Ravula, T., Ramadugu, S. K., Sahoo, B. R., Kikuchi, J.-I., & Ramamoorthy, A. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b10591 · Cited by 132
Fragment Screening of Stabilized G-Protein-Coupled Receptors Using Biophysical Methods
Congreve, M., Rich, R. L., Myszka, D. G., Figaroa, F., Siegal, G., & Marshall, F. H. (2011) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-381274-2.00005-4 · Cited by 125
Thermostabilisation of an Agonist-Bound Conformation of the Human Adenosine A2A Receptor
Lebon, G., Bennett, K. A., Jazayeri, A., & Tate, C. G. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.03.075 · Cited by 125
Applying Structure-Based Drug Design Approaches to Allosteric Modulators of GPCRs
Congreve, M., Oswald, C., & Marshall, F. H. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.05.010 · Cited by 123
Klein‐Seetharaman, J., Getmanova, E. V., Loewen, M. C., Reeves, P. J., & Khorana, H. G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.13744 · Cited by 123
GPCR structures in drug design, emerging opportunities with new structures
Tautermann, C. S. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.07.009 · Cited by 120
Biased G Protein-Coupled Receptor Signaling: New Player in Modulating Physiology and Pathology
Bologna, Z., Teoh, J., Bayoumi, A., Tang, Y., & Kim, I. (2016) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2016.165 · Cited by 117
Modulation of the Interaction between Neurotensin Receptor NTS1 and Gq Protein by Lipid
Inagaki, S., Ghirlando, R., White, J. F., Gvozdenovic‐Jeremic, J., Northup, J. K., & Grisshammer, R. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2012.01.023 · Cited by 115
Involvement of distinct arrestin-1 elements in binding to different functional forms of rhodopsin
Zhuang, T., Chen, Q., Cho, M., Vishnivetskiy, S. A., Iverson, T. M., Gurevich, V. V., & Sanders, C. R. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1215176110 · Cited by 114
Mary, S., Damian, M., Louet, M., Floquet, N., Fehrentz, J., Marie, J., Martínez, J., & Banères, J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119881109 · Cited by 114
β-arrestin–biased signaling through the β 2 -adrenergic receptor promotes cardiomyocyte contraction
Carr, R., Schilling, J., Song, J., Carter, R. L., Du, Y., Yoo, S. M., Traynham, C. J., Koch, W. J., Cheung, J. Y., Tilley, D. G., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1606267113 · Cited by 113
Allostery and biased agonism at class B G protein-coupled receptors
Wootten, D., Miller, L. J., Koole, C., Christopoulos, A., & Sexton, P. M. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00049 · Cited by 112
Grunbeck, A., Huber, T., Sachdev, P., & Sakmar, T. P. (2011) · Biochemistry · doi:10.1021/bi200214r · Cited by 112
Role of Detergents in Conformational Exchange of a G Protein-coupled Receptor
Chung, K. Y., Kim, T. H., Manglik, A., Alvares, R. D. A., Kobilka, B. K., & Prosser, R. S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.406371 · Cited by 112
Lamichhane, R., Liu, J. J., Pljevaljčić, G., White, K. L., der Schans, E. J. C. V., Katritch, V., Stevens, R. C., Wüthrich, K., & Millar, D. P. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1519626112 · Cited by 111
Self-citationG protein-coupled receptors as targets for anti-diabetic therapeutics
Oh, D. Y., & Olefsky, J. M. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.4 · Cited by 111
Solt, A., Bostock, M. J., Shrestha, B., Kumar, P., Warne, T., Tate, C. G., & Nietlispach, D. (2017) · Nature Communications · doi:10.1038/s41467-017-02008-y · Cited by 110
Zhang, X., Zhao, F., Wu, Y., et al. (2017) · Nature Communications · doi:10.1038/ncomms15383 · Cited by 109
Novel Structural Insights into GPCR–β-Arrestin Interaction and Signaling
Ranjan, R., Dwivedi‐Agnihotri, H., Baidya, M., Kumar, M., & Shukla, A. K. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.05.008 · Cited by 106
Structured and disordered facets of the GPCR fold
Venkatakrishnan, A., Flock, T., Prado, D. E., Oates, M. E., Gough, J., & Babu, M. M. (2014) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2014.08.002 · Cited by 103
Mediavilla-Varela, M., Luddy, K. A., Noyes, D. R., Khalil, F. K., Neuger, A. M., Soliman, H. H., & Antonia, S. J. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.25643 · Cited by 102
NMR structure and dynamics of the agonist dynorphin peptide bound to the human kappa opioid receptor
O’Connor, C., White, K. L., Doncescu, N., Didenko, T., Roth, B. L., Czaplicki, G., Stevens, R. C., Wüthrich, K., & Milon, A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1510117112 · Cited by 99
Self-citationConformational dynamics of a G-protein α subunit is tightly regulated by nucleotide binding
Goričanec, D., Stehle, R., Egloff, P., Grigoriu, S., Plückthun, A., Wagner, G., & Hagn, F. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1604125113 · Cited by 97
Fluorine-19 NMR of integral membrane proteins illustrated with studies of GPCRs
Didenko, T., Liu, J. J., Horst, R., Stevens, R. C., & Wüthrich, K. (2013) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2013.07.011 · Cited by 96
Self-citationThe molecular basis of subtype selectivity of human kinin G-protein-coupled receptors
Joedicke, L., Mao, J., Kuenze, G., Reinhart, C., Kalavacherla, T., Jonker, H. R. A., Richter, C. P., Schwalbe, H., Meiler, J., Preu, J., et al. (2018) · Nature Chemical Biology · doi:10.1038/nchembio.2551 · Cited by 96
Recent updates on GPCR biased agonism
Pupo, A. S., Duarte, D. Â., Lima, V., Teixeira, L. B., Parreiras‐e‐Silva, L. T., & Costa-Neto, C. M. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.01.031 · Cited by 94
Conformational equilibria of light-activated rhodopsin in nanodiscs
Eps, N. V., Caro, L. N., Morizumi, T., Kusnetzow, A. K., Szczepek, M., Hofmann, K. P., Bayburt, T. H., Sligar, S. G., Ernst, O. P., & Hubbell, W. L. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1620405114 · Cited by 94
Ligand modulation of sidechain dynamics in a wild-type human GPCR
Clark, L. D., Dikiy, I., Chapman, K., Rödström, K. E. J., Aramini, J. M., Levine, M. V., Khelashvili, G., Rasmussen, S. G. F., Gardner, K. H., & Rosenbaum, D. M. (2017) · eLife · doi:10.7554/elife.28505 · Cited by 94
Applications of NMR to membrane proteins
Opella, S. J., & Marassi, F. M. (2017) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2017.05.011 · Cited by 92
A Structure–Activity Analysis of Biased Agonism at the Dopamine D2 Receptor
Shonberg, J., Herenbrink, C. K., López, L., Christopoulos, A., Scammells, P. J., Capuano, B., & Lane, J. R. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401318w · Cited by 91
β2‐Adrenergic Receptor Activation by Agonists Studied with 19F NMR Spectroscopy
Horst, R., Liu, J. J., Stevens, R. C., & Wüthrich, K. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201305286 · Cited by 91
Self-citationChen, D., Errey, J. C., Heitman, L. H., Marshall, F. H., IJzerman, A. P., & Siegal, G. (2012) · ACS Chemical Biology · doi:10.1021/cb300436c · Cited by 88
From G Protein-coupled Receptor Structure Resolution to Rational Drug Design
Jazayeri, A., Dias, J. M., & Marshall, F. H. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.668251 · Cited by 85
London, R. E., Wingad, B. D., & Mueller, G. A. (2008) · Journal of the American Chemical Society · doi:10.1021/ja802729t · Cited by 85
Structure and Function of Peptide-Binding G Protein-Coupled Receptors
Wu, F., Song, G., de Graaf, C., & Stevens, R. C. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.06.022 · Cited by 85
Shiraishi, Y., Natsume, M., Kofuku, Y., Imai, S., Nakata, K., Mizukoshi, T., Ueda, T., Iwaï, H., & Shimada, I. (2018) · Nature Communications · doi:10.1038/s41467-017-02632-8 · Cited by 79
Self-citationGPCRs and Signal Transducers: Interaction Stoichiometry
Gurevich, V. V., & Gurevich, E. V. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.04.002 · Cited by 78
Emerging Approaches to GPCR Ligand Screening for Drug Discovery
Kumari, P., Ghosh, E., & Shukla, A. K. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.09.002 · Cited by 77
New Technologies for Elucidating Opioid Receptor Function
Bruchas, M. R., & Roth, B. L. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.01.001 · Cited by 76
Assadi‐Porter, F. M., Tonelli, M., Maillet, É. L., Hallenga, K., Benard, O., Max, M., & Markley, J. L. (2008) · Journal of the American Chemical Society · doi:10.1021/ja8016939 · Cited by 75
Structural mechanism of arrestin activation
Scheerer, P., & Sommer, M. E. (2017) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2017.05.001 · Cited by 75
Bocquet, N., Kohler, J., Hug, M. N., Kusznir, E. A., Rufer, A. C., Dawson, R. J. P., Hennig, M., Ruf, A., Huber, W., & Huber, S. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.02.014 · Cited by 74
Structurally Enabled Discovery of Adenosine A 2A Receptor Antagonists
Jazayeri, A., Andrews, S. P., & Marshall, F. H. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00119 · Cited by 74
Yoshiura, C., Kofuku, Y., Ueda, T., Mase, Y., Yokogawa, M., Osawa, M., Terashima, Y., Matsushima, K., & Shimada, I. (2010) · Journal of the American Chemical Society · doi:10.1021/ja100830f · Cited by 73
Self-citationCarpenter, B., & Tate, C. G. (2017) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2017.04.010 · Cited by 73
Ni, Q. Z., Can, T. V., Daviso, E., Belenky, M., Griffin, R. G., & Herzfeld, J. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b00022 · Cited by 73
Structure‐Based and Fragment‐Based GPCR Drug Discovery
Andrews, S. P., Brown, G. A., & Christopher, J. A. (2013) · ChemMedChem · doi:10.1002/cmdc.201300382 · Cited by 72
The importance of ligands for G protein-coupled receptor stability
Zhang, X., Stevens, R. C., & Xu, F. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.12.005 · Cited by 71
Understanding the GPCR biased signaling through G protein and arrestin complex structures
Zhou, X. E., Melcher, K., & Xu, H. E. (2017) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2017.05.004 · Cited by 71
Cited by
Common activation mechanism of class A GPCRs
Zhou, Q., Yang, D., Wu, M., Guo, Y., Guo, W., Zhong, L., Cai, X., Dai, A., Jang, W., Shakhnovich, E. I., et al. (2019) · eLife · doi:10.7554/elife.50279 · Cited by 632
G protein-coupled receptors: structure- and function-based drug discovery
Yang, D., Zhou, Q., Labroska, V., Qin, S., Darbalaei, S., Wu, Y., Yuliantie, E., Xie, L., Tao, H., Cheng, J., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00435-w · Cited by 632
G protein-coupled receptors (GPCRs): advances in structures, mechanisms and drug discovery
Zhang, M., Chen, T., Lu, X., Lan, X., Chen, Z., & Lu, S. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01803-6 · Cited by 491
Cheng, P. T. W., Kaltenbach, R. F., Zhang, H., Shi, J., Tao, S., Li, J., Kennedy, L. J., Walker, S. J., Shi, Y., Wang, Y., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01256 · Cited by 61
Modeling of protein conformational changes with Rosetta guided by limited experimental data
Sala, D., del Alamo, D., Mchaourab, H. S., & Meiler, J. (2022) · Structure · doi:10.1016/j.str.2022.04.013 · Cited by 30
Metadata
- Authors
- Shimada, I., Ueda, T., Kofuku, Y., Eddy, M. T., & Wüthrich, K.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2018-11-09
- Volume
- 18
- Issue
- 1
- Pages
- 59-82
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2899596245
- Cited by
- 279
- References
- 254
- FWCI
- 2.41
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.